Envista Holdings Corp
NYSE:NVST · New York Stock Exchange
+$0.76 today
Vol 1.62M · Avg 2.94M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+37.09%
Period High
$30.26
Period Low
$18.89
Latest
$25.91
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.42B
Alignment Healthcare, Inc.
NASDAQ:ALHC
$4.51B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.64B
ICU Medical, Inc.
NASDAQ:ICUI
$3.46B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.25B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.97B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.69B
GRAIL, Inc.
NASDAQ:GRAL
$2.65B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.55B
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
$2.03B
What is the latest NVST filing?
The latest filing shown is 8-K dated Jun 3, 2026.
How many recent filings does NVST have?
Intrinsic Alpha currently shows 20 recent filings for NVST.
Explore More
Continue the stock analysis
Jump to another research area for this company.